Association of histone deacetylase genes with schizophrenia in Korean population

Psychiatry Research

Volumn 178, Issue 2, 2010, Pages 266-269

  Kim, Tae ^a   Park, Jin Kyung ^b   Kim, Hak Jae ^c   Chung, Joo Ho ^c   Kim, Jong Woo ^b  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b Kyung Hee University College of Medicine   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

Case control study; Genetic association; Histone deacetylase; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4;

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANALYSIS OF VARIANCE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISTONE DEACETYLASES; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 77953809223     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.05.007     Document Type: Article

References (30)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press.
2. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Archives of General Psychiatry 1982, 39:784-788.
3. Bjerling P., Silverstein R.A., Thon G., Caudy A., Grewal S., Ekwall K. Functional divergence between histone deacetylases in fission yeast by distinct cellular localization and in vivo specificity. Molecular and Cellular Biology 2002, 22:2170-2181.
4. Bland J.M., Altman D.G. Multiple significance tests: the Bonferroni method. British Medical Journal 1995, 310:170.
5. Cardno A.G., Jones L.A., Murphy K.C., Asherson P., Scott L.C., Williams J., Owen M.J., McGuffin P. Factor analysis of schizophrenic symptoms using the OPCRIT checklist. Schizophrenia Research 1996, 22:233-239.
6. Chen Y., Sharma R.P., Costa R.H., Costa E., Grayson D.R. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Research 2002, 30:2930-2939.
7. Costa E., Chen Y., Davis J., Dong E., Noh J.S., Tremolizzo L., Veldic M., Grayson D.R., Guidotti A. Reelin and schizophrenia: a disease at the interface of the genome and the epigenome. Molecular Intervention 2002, 2:47-57.
8. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. American Journal of Psychiatry 1998, 155:1490-1501.
9. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochemical Journal 2003, 370:737-749.
10. Fanous A.H., van den Oord E.J., Riley B.P., Aggen S.H., Neale M.C., O'Neill F.A., Walsh D., Kendler K.S. Relationship between a high-risk haplotype in the dtnbp1 (dysbindin) gene and clinical features of schizophrenia. American Journal of Psychiatry 2005, 162:1824-1832.
11. Fischle W., Dequiedt F., Hendzel M.J., Guenther M.G., Lazar M.A., Voelter W., Verdin E. Enzymatic activity associated with class ii HDACs is dependent on a multiprotein complex containing hdac3 and smrt/n-cor. Molecular Cell 2002, 9:45-57.
12. Flemenbaum A., Zimmermann R.L. Inter- and intra-rater reliability of the brief psychiatric rating scale. Psychological Reports 1973, 32:783-792.
13. Gao L., Cueto M.A., Asselbergs F., Atadja P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. The Journal of Biological Chemistry 2002, 277:25748-25755.
14. Glassman A.H. Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry 1993, 150:546-553.
15. Grozinger C.M., Hassig C.A., Schreiber S.L. Three proteins define a class of human histone deacetylases related to yeast hda1p. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:4868-4873.
16. Grozinger C.M., Schreiber S.L. Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chemical Biology 2002, 9:3-16.
17. Huang H.S., Akbarian S. GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS ONE 2007, 2:e809.
18. Huang H.S., Matevossian A., Whittle C., Kim S.Y., Schumacher A., Baker S.P., Akbarian S. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. Journal of Neuroscience 2007, 27:11254-11262.
19. Issidorides M.R., Stefanis C.N., Varsou E., Katsorchis T. Altered chromatin ultrastructure in neutrophils of schizophrenics. Nature 1975, 258:612-614.
20. Issidorides M.R., Zioudrou C., Lykouras E., Stefanis C.N. Drug-induced changes in chromatin ultrastructure and nuclear basic proteins of the neutrophils of chronic schizophrenics. Progress in Neuropsychopharmacology 1978, 2:79-85.
21. Kimchi-Sarfaty C., Oh J.M., Kim I.W., Sauna Z.E., Calcagno A.M., Ambudkar S.V., Gottesman M.M. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Sience 2006, 315:525-528.
22. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry 1991, 48:764-770.
23. Nencioni A., Beck J., Werth D., Grunebach F., Patrone F., Ballestrero A., Brossart P. Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clinical Cancer Research 2007, 13:3933-3941.
24. Petronis A., Paterson A.D., Kennedy J.L. Schizophrenia: an epigenetic puzzle?. Schizophrenia Bulletin 1999, 25:639-655.
25. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
26. Rickham P.P. Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki. British Medical Journal 1964, 2:177.
27. Roth S.Y., Denu J.M., Allis C.D. Histone acetyltransferases. Annual Review of Biochemistry 2001, 70:81-120.
28. Sharma R.P. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophrenia Research 2005, 72:79-90.
29. Solé X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
30. Struhl K. Fundamentally different logic of gene regulation in eukaryotes and prokaryotes. Cell 1999, 98:1-4.